297 related articles for article (PubMed ID: 15545262)
1. Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is indirect and mediated by bone morphogenetic proteins.
Winkler DG; Sutherland MS; Ojala E; Turcott E; Geoghegan JC; Shpektor D; Skonier JE; Yu C; Latham JA
J Biol Chem; 2005 Jan; 280(4):2498-502. PubMed ID: 15545262
[TBL] [Abstract][Full Text] [Related]
2. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
[TBL] [Abstract][Full Text] [Related]
3. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells.
Luo Q; Kang Q; Si W; Jiang W; Park JK; Peng Y; Li X; Luu HH; Luo J; Montag AG; Haydon RC; He TC
J Biol Chem; 2004 Dec; 279(53):55958-68. PubMed ID: 15496414
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms.
Dai J; Hall CL; Escara-Wilke J; Mizokami A; Keller JM; Keller ET
Cancer Res; 2008 Jul; 68(14):5785-94. PubMed ID: 18632632
[TBL] [Abstract][Full Text] [Related]
5. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
6. Wnt-3A enhances bone morphogenetic protein-2-mediated chondrogenesis of murine C3H10T1/2 mesenchymal cells.
Fischer L; Boland G; Tuan RS
J Biol Chem; 2002 Aug; 277(34):30870-8. PubMed ID: 12077113
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of GSK3β Stimulates BMP Signaling and Decreases SOST Expression Which Results in Enhanced Osteoblast Differentiation.
Schoeman MA; Moester MJ; Oostlander AE; Kaijzel EL; Valstar ER; Nelissen RG; Löwik CW; de Rooij KE
J Cell Biochem; 2015 Dec; 116(12):2938-46. PubMed ID: 26095393
[TBL] [Abstract][Full Text] [Related]
8. Noggin and sclerostin bone morphogenetic protein antagonists form a mutually inhibitory complex.
Winkler DG; Yu C; Geoghegan JC; Ojala EW; Skonier JE; Shpektor D; Sutherland MK; Latham JA
J Biol Chem; 2004 Aug; 279(35):36293-8. PubMed ID: 15199066
[TBL] [Abstract][Full Text] [Related]
9. Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts.
Kamiya N; Kobayashi T; Mochida Y; Yu PB; Yamauchi M; Kronenberg HM; Mishina Y
J Bone Miner Res; 2010 Feb; 25(2):200-10. PubMed ID: 19874086
[TBL] [Abstract][Full Text] [Related]
10. Wnt signaling during BMP-2 stimulation of mesenchymal chondrogenesis.
Fischer L; Boland G; Tuan RS
J Cell Biochem; 2002; 84(4):816-31. PubMed ID: 11835406
[TBL] [Abstract][Full Text] [Related]
11. Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts.
Nakashima A; Katagiri T; Tamura M
J Biol Chem; 2005 Nov; 280(45):37660-8. PubMed ID: 16150699
[TBL] [Abstract][Full Text] [Related]
12. Activated beta-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction.
Bain G; Müller T; Wang X; Papkoff J
Biochem Biophys Res Commun; 2003 Jan; 301(1):84-91. PubMed ID: 12535644
[TBL] [Abstract][Full Text] [Related]
13. BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway.
Kamiya N; Ye L; Kobayashi T; Mochida Y; Yamauchi M; Kronenberg HM; Feng JQ; Mishina Y
Development; 2008 Nov; 135(22):3801-11. PubMed ID: 18927151
[TBL] [Abstract][Full Text] [Related]
14. Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist.
van Bezooijen RL; Roelen BA; Visser A; van der Wee-Pals L; de Wilt E; Karperien M; Hamersma H; Papapoulos SE; ten Dijke P; Löwik CW
J Exp Med; 2004 Mar; 199(6):805-14. PubMed ID: 15024046
[TBL] [Abstract][Full Text] [Related]
15. Canonical Wnts and BMPs cooperatively induce osteoblastic differentiation through a GSK3beta-dependent and beta-catenin-independent mechanism.
Fukuda T; Kokabu S; Ohte S; Sasanuma H; Kanomata K; Yoneyama K; Kato H; Akita M; Oda H; Katagiri T
Differentiation; 2010 Jul; 80(1):46-52. PubMed ID: 20546990
[TBL] [Abstract][Full Text] [Related]
16. Regulation of matrix metalloproteinase-13 and tissue inhibitor of matrix metalloproteinase-1 gene expression by WNT3A and bone morphogenetic protein-2 in osteoblastic differentiation.
Nakashima A; Tamura M
Front Biosci; 2006 May; 11():1667-78. PubMed ID: 16368545
[TBL] [Abstract][Full Text] [Related]
17. A dishevelled-1/Smad1 interaction couples WNT and bone morphogenetic protein signaling pathways in uncommitted bone marrow stromal cells.
Liu Z; Tang Y; Qiu T; Cao X; Clemens TL
J Biol Chem; 2006 Jun; 281(25):17156-17163. PubMed ID: 16621789
[TBL] [Abstract][Full Text] [Related]
18. Modulation of sclerostin expression by mechanical loading and bone morphogenetic proteins in osteogenic cells.
Papanicolaou SE; Phipps RJ; Fyhrie DP; Genetos DC
Biorheology; 2009; 46(5):389-99. PubMed ID: 19940355
[TBL] [Abstract][Full Text] [Related]
19. Hedgehog stimulates only osteoblastic differentiation of undifferentiated KS483 cells.
van der Horst G; Farih-Sips H; Löwik CW; Karperien M
Bone; 2003 Dec; 33(6):899-910. PubMed ID: 14678849
[TBL] [Abstract][Full Text] [Related]
20. Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells.
Peng Y; Kang Q; Luo Q; Jiang W; Si W; Liu BA; Luu HH; Park JK; Li X; Luo J; Montag AG; Haydon RC; He TC
J Biol Chem; 2004 Jul; 279(31):32941-9. PubMed ID: 15161906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
